HER2/neu testing in primary colorectal carcinoma

BACKGROUND: Anti-HER2/neu therapy is well-established in breast and gastric carcinoma. The increased understanding of this pathway led to the identification of new promising drugs in addition to trastuzumab, offering further perspectives. The role of HER2/neu in colorectal carcinoma is controversial...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Br J Cancer
Autores principales: Ingold Heppner, B, Behrens, H-M, Balschun, K, Haag, J, Krüger, S, Becker, T, Röcken, C
Formato: Artigo
Lenguaje:Inglês
Publicado: Nature Publishing Group 2014
Materias:
Molecular Diagnostics
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4229629/
https://ncbi.nlm.nih.gov/pubmed/25211663
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2014.483
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares